ArticleInternational urology and nephrology2026
Suspected adrenal insufficiency in hemodialysis patients with recurrent intradialytic hypotension.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntradialytic hypotension (IDH) is a frequent complication of maintenance hemodialysis and is associated with increased morbidity. The role of adrenal insufficiency (AI) as a potential contributor to recurrent IDH remains insufficiently characterized.
objectiveTo evaluate the prevalence of adrenal insufficiency among hemodialysis patients with recurrent intradialytic hypotension and to examine associated clinical and biochemical characteristics.
methodsIn this cross-sectional study, adult patients undergoing maintenance hemodialysis who experienced recurrent intradialytic hypotension were recruited from a tertiary dialysis center. Morning serum cortisol and plasma adrenocorticotropic hormone (ACTH) were measured prior to dialysis. Patients were classified as having suspected adrenal insufficiency if their serum cortisol levels were less than 18 μg/dL. Clinical and laboratory parameters were compared between adrenal insufficient and adrenal-sufficient patients.
resultsFifty-one hemodialysis patients with recurrent intradialytic hypotension were evaluated. The mean age was 52.35 ± 13.6 years, and 37.2% were male. Adrenal insufficiency was identified in 37 patients (72.5%). Based on basal ACTH levels, 4 patients (7.8%) were classified as suspected primary AI and 33 (64.7%) as suspected secondary AI. No significant differences were observed between groups regarding age, sex, dialysis vintage, or interdialytic weight gain. Adrenal insufficient patients demonstrated significantly lower serum sodium and random blood glucose levels and higher serum potassium levels compared with adrenal-sufficient patients (p < 0.05).
conclusionAdrenal insufficiency was frequently detected among hemodialysis patients with recurrent intradialytic hypotension in this single-center cohort. Biochemical findings were compatible with impaired adrenal function. Further studies are required to validate diagnostic thresholds in this population and to determine the therapeutic implications of identifying adrenal dysfunction in patients with intradialytic hypotension.
Indexed as
Identifiers
42507289What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.